The Alliance and our partner organizations host various events to raise awareness about the field of aging research and to present the latest innovations and advancements that are helping extend people’s healthspans. Those events are featured here.


Start Date: November 29th, 2012

Start Time: 7:30AM

End Time: 2:00PM

City: Rockville, MD

Contact Address: Hilton Executive Meeting Center, 1750 Rockville Pike Rockville, MD 20852

To address critical issues in the development of new Alzheimer’s disease treatments, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) coalition and the Critical Path Institute will co-host the fifth-annual FDA/AD Allies Meeting. This annual meeting sponsored by ACT-AD brings together leaders in Alzheimer’s drug development from the patient advocacy community, federal health and regulatory agencies, academic research, and the private sector for focused discussions on key issues surrounding the development and regulation of Alzheimer’s drugs and therapies.

Combination therapy development has been successful in other life-threatening diseases in part because collaborative approaches were established to identify necessary pathways and tools that enabled more efficient trials. Our primary goal is to explore how similar partnerships could foster more robust collaboration in Alzheimer’s disease (AD) in order to encourage the development of combination therapies.

FDA has published draft guidance on the co-development of multiple treatments for use in combination. This meeting will allow stakeholders to gain greater clarity of FDA’s requirements for the development of multiple therapies in combination for the treatment of Alzheimer’s disease and explore the feasibility of practically designing clinical trials for more than one AD therapy.

Related Topics: Alzheimer's Disease

Living Longer & Loving It

Sign up for our electronic newsletter Living Longer & Loving It